Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1

Status

Withdrawn 4Unknown 4Terminated 3Recruiting 2Active not recruiting 2

Sponsor Class

OTHER 4

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Gastrointestinal 4

Conditions

Breast Neoplasms 64Colorectal Neoplasms 58Rectal Neoplasms 46Stomach Neoplasms 44Neoplasm Metastasis 16Pancreatic Neoplasms 15Colonic Neoplasms 13Triple Negative Breast Neoplasms 11Neoplasms 11Esophageal Neoplasms 9Nasopharyngeal Carcinoma 8Locally Advanced Rectal Cancer 7Esophageal Squamous Cell Carcinoma 7Cholangiocarcinoma 6Biliary Tract Neoplasms 6Carcinoma, Hepatocellular 5HER2 Positive Metastatic Breast Cancer 4Colorectal Cancer Metastatic 4Adenocarcinoma 4Solid Tumor 3Recurrence 3Gallbladder Neoplasms 3Anus Neoplasms 3Advanced Breast Cancer 3Squamous Cell Carcinoma of Head and Neck 2Solid Tumors 2Neuroendocrine Tumors 2Locally Advanced Colon Cancer 2Hyperthermia 2Head and Neck Neoplasms 2

Interventions

Oxaliplatin 5Irinotecan 5Panitumumab 4Capecitabine 4Bevacizumab 4Cetuximab 3Leucovorin 2Fluorouracil 2trifluridine tipiracil drug combination 1spartalizumab 1regorafenib 1raltitrexed 1pembrolizumab 1camrelizumab 1aflibercept 1XELOX 1Radiotherapy 1Radiosurgery 1Lycopene 1Loperamide 1Ethiodized Oil 1Drug Therapy 1Cytoreduction Surgical Procedures 1Antineoplastic Agents 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Unknown × Colorectal Cancer Metastatic × Capecitabine × Clear all
NCT04262687 2023-08-18

POCHI

Federation Francophone de Cancerologie Digestive

Phase 2 Unknown
55 enrolled
Gastrointestinal

Colorectal Cancer Metastatic

NCT03923036 2019-04-22

AVOCETTE

University Hospital, Caen

Unknown
2,000 enrolled
Gastrointestinal

Colorectal Cancer Metastatic

NCT03792269 2019-01-03

Intraperitoneal and System Chemotherapy Versus XELOX as First-line Chemotherapy for mCRC

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

Phase 2 Unknown
100 enrolled
Gastrointestinal

Colorectal Cancer Metastatic

NCT01249638 2011-03-14

Cap+Bev vs Cap+Iri+Bev 1st-line Therapy in mCRC

Ludwig-Maximilians - University of Munich

Phase 3 Unknown
516 enrolled
Gastrointestinal

Colorectal Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡